Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 60 2012 057 324.4 |
96 | EP file number | EAKZ | 16 17 4214.3 |
97 | EP publication number | EPN | 3106165 |
54 | Designation/title | TI | VERFAHREN UND ARZNEIMITTELPRODUKTE ZUR BEHANDLUNG VON MORBUS ALZHEIMER |
51 | IPC main class | ICM (ICMV) | A61K 31/4436 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | C12Q 1/68 (2018.01), A61K 31/4439 (2006.01), C07D 417/12 (2006.01) |
22 | DE application date | DAT | Jan 9, 2012 |
96 | EP application date | EAT | Jan 9, 2012 |
43 | Date of first publication | OT | Dec 21, 2016 |
| Date of publication of grant | PET | Feb 27, 2019 |
71/73 | Applicant/owner | INH | Zinfandel Pharmaceuticals, Inc., Chapel Hill, NC, US |
72 | Inventor | IN | ROSES, Allen D., Chapel Hill, NC North Carolina 27517, US; TANEJA, Rajneesh, Libertyville, IL Illinois 60048, US |
74 | Representative | VTR | Hernandez, Yorck, Dipl.-Ing., 82031 Grünwald, DE |
| Address for service | | HERNANDEZ IP, 82031 Grünwald, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201161431370 P Jan 10, 2011
|
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000003106165A1 Searchable text:
EP000003106165A1 Original document:
EP000003106165B1 Searchable text:
EP000003106165B1 |
43 | Date of first publication | EVT | Dec 21, 2016 |
| Date of the first transfer into DPMAregister | EREGT | Dec 22, 2016 |
| Date of the (most recent) update in DPMAregister | REGT | Oct 26, 2023 (Show all update days)(Hide all update days)- Oct 26, 2023; Sep 16, 2023; Nov 19, 2021; Jul 8, 2021; Jan 22, 2021; Dec 5, 2020; Dec 3, 2020; Feb 7, 2020; Jan 16, 2020; Aug 8, 2019; Jul 25, 2019; Jun 28, 2019; Mar 21, 2019; Feb 8, 2019; Feb 7, 2019; Nov 30, 2017
- Historical data not available for this/these date(s)
- Dec 22, 2016
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 5)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Jun 27, 2019 |
| Issue number | HN | 32 |
| Year | PJ | 2019 |
| Publication date | VT | Aug 8, 2019 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
71/73 | Applicant/owner | INH | Zinfandel Pharmaceuticals, Inc., Chapel Hill, NC, US |
71/73 | Previous applicant/owner | INHF | Takeda Pharmaceutical Company Limited, Osaka-shi, JP, Zinfandel Pharmaceuticals, Inc., Durham, N.C., US |